Protein kinase a serves as a primary pathway in activation of Nur77 expression by gonadotropin-releasing hormone in the LβT2 mouse pituitary gonadotroph tumor cell line

International Journal of Oncology

Volumn 33, Issue 5, 2008, Pages 1055-1064

  Hamid, Tariq ^a   Malik, Mohammed T ^a   Millar, Robert P ^b,c   Kakar, Sham S ^a  

^a University of Louisville School of Medicine   (United States)

^b MRC Reproductive Biology Unit   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cancer; Gonadotropin releasing hormone signaling; L T2; Nur77; Pituitary; Protein kinase A; Protein kinase C

Indexed keywords

8 BROMO CYCLIC AMP; CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EGTAZIC ACID; FORSKOLIN; GONADORELIN; GONADORELIN DERIVATIVE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NUCLEAR RECEPTOR NUR77; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; CHELATING AGENT; DNA BINDING PROTEIN; DRUG DERIVATIVE; ENZYME ACTIVATOR; LHRH, ALA(6) GLY(10) ETHYLAMIDE; LHRH, ALA(6)-GLY(10)-ETHYLAMIDE-; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE INHIBITOR; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; GENE EXPRESSION; GONADOTROPH ADENOMA; MOLECULAR MECHANICS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; GENETICS; GONADOTROPIN SECRETING CELL; HYPOPHYSIS TUMOR; METABOLISM; PATHOLOGY; TIME; TUMOR CELL LINE;

ANIMALS; CALCIUM; CELL LINE, TUMOR; CHELATING AGENTS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATORS; GONADOTROPHS; GONADOTROPIN-RELEASING HORMONE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PITUITARY NEOPLASMS; PROTEIN KINASE INHIBITORS; RECEPTORS, STEROID; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; UP-REGULATION;

EID: 58149176620     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000094     Document Type: Article

References (94)

1. Law SW, Conneely OM, DeMayo FJ and O'Malley BW: Identification of a new brain-specific transcription factor, NURR1. Mol Endocrinol 6: 2129-2135, 1992.
2. Ohkura N, Hijikuro M, Yamamoto A and Miki K: Molecular cloning of a novel thyroid/steroid receptor superfamily gene from cultured rat neuronal cells. Biochem Biophys Res Commun 205: 1959-1965, 1994.
3. Milbrandt J: Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1: 183-188, 1988.
4. Hazel TG, Nathans D and Lau LF: A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc Natl Acad Sci USA 85: 8444-8448, 1988.
5. Fahrner TJ, Carroll SL and Milbrandt J: The NGF-1B protein, and inducible member of the thyroid/steroid receptor family, is rapidly modified posttranslationally. Mol Cell Biol 10: 6454-6459, 1990.
6. Pei L, Castrillo A, Chen M, Hoffmann A and Tontonoz P: Induction of NR4A orphan receptor expression in macrophages in response to inflammatory stimuli. J biol Chem 280: 29256-29262, 2005.
7. Kovalovsky D, Paez Pereda M, Labeur M, Renner U, Holsboer F, Stalla GK and Arzt E: Nur77 induction and activation are necessary for interleukin-1 stimulation of proopiomelanocortin in AtT-20 corticotrophs. FEBS Lett 563: 229-233, 2004.
8. Jimenez-Cervantes C, Pichon B, Dumont JE and Maenhaut C: Activation by thyroid stimulating hormone of nerve growth factor-induced gene-B expression in thyrocytes in culture: relation with proliferation and specific gene expression. Biochim Biophys Acta 1403: 232-244, 1988.
9. Wilson AJ, Arango D, Mariadason JM, Heerdt BG and Augenlicht LH: TR3/ Nur77 in colon cancer cell apoptosis. Cancer Res 63: 5401-5407, 2003.
10. Song KH, Park JI, Lee MO, Soh J, Lee K and Choi HS: LH induces orphan nuclear receptor Nur77 gene expression in testicular Leydig cells. Endocrinology 142: 5116-5123, 2001.
11. Chintharlapalli S, Burghardt R, Papineni S, Ramaiah S, Yoon K and Safe S: Activation of Nur77 by selected 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways. J Biol Chem 280: 24903-24914, 2005.
12. Song KH, Park, YY, Park KC, Hong CY, Park JH, Shong M, Lee K and Choi HS: The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation. Mol Endocrinol 18: 1929-1940, 2004.
13. Predki PF, Zamble D, Sarkar B and Giguere V: Ordered binding of retinoic acid and retinoid-X receptors to asymmetric response elements involves determinants adjacent to the DNA-binding domain. Mol Endocrinol 8: 31-39, 1994.
14. Kang HJ, Song MR, Lee SK, Shin EC, Choi YH, Kim SJ, Lee JW and Lee MO: Retinoic acid and its receptors repress the expression and transactivation functions of Nur77: a possible mechanism for the inhibition of apoptosis by retinoic acid. Exp Cell Res 256: 545-554, 2000.
15. Wu WS, Xu ZX, Ran R, Meng F and Chang KS: Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions. Oncogene 21: 3925-3933, 2002.
16. Maira M, Martens C, Batsche E, Gauthier Y and Drouin J: Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Mol Cell Biol 23: 763-776, 2003.
17. Sohn YC, Kwak E, Na Y, Lee JW and Lee SK: Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor Nur77. J Biol Chem 276: 43734-43739, 2001.
18. Wilson TE, Mouw AR, Weaver CA, Milbrandt J and Parker KL: The orphan nuclear receptor NGFI-B regulates expression of the gene encoding steroid 21-hydroxylase. Mol Cell Biol 13: 861-868, 1993.
19. Crawford PA, Sadovsky Y, Woodson K, Lee SL and Milbrandt J: Adrenocortical function and regulation of the steroid 21-hydroxylase gene in NGFI-B-deficient mice. Mol Cell Biol 15: 4331-4336, 1995.
20. Fernandez PM, Brunel F, Jimenez MA, Saez, JM, Cereghini S and Zakin MM: Nuclear receptors Nor1 and NGFI-B/Nur77 play similar, albeit distinct, roles in the hypothalamo-pituitary-adrenal axis. Endocrinology 141: 2392-2400, 2000.
21. Stocco CO, Zhong L, Sugimoto Y, Ichikawa A, Lau LF and Gibori G: Prostaglandin F2alpha-induced expression of 20alpha-hydroxysteroid dehydrogenase involves the transcription factor NUR77. J Biol Chem 275: 37202-37211, 2000.
22. Liu ZG, Smith SW, McLaughlin KA, Schwartz LM and Osborne BA: Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367: 281-284, 1994.
23. Cheng LE, Chan FK, Cado D and Winoto A: Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J 16: 1865-1875, 1997.
24. Li Y, Lin B, Agadir A, Liu R, Dawson MI, Reed JC, Fontana JA, Bost F, Hobbs PD, Zheng Y, Chen GQ, Shroot B, Mercola D and Zhang XK: Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol Cell Biol 18: 4719-47131, 1998.
25. Uemura H and Chang C: Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment. Endocrinology 139: 2329-2334, 1998.
26. Woronicz JD, Calnan B, Ngo V and Winoto A: Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367: 277-281, 1994.
27. He YW: Orphan nuclear receptors in T lymphocyte development. J Leukoc Biol 72: 440-446, 2002.
28. Calnan BJ, Szychowski S, Chan FK, Cado D and Winoto A: A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 3: 273-282, 1995.
29. Hazel TG, Misra R, Davis IJ, Greenberg ME and Lau LF: Nur77 is differentially modified in PC12 cells upon membrane depolarization and growth factor treatment. Mol Cell Biol 11: 3239-3246, 1991.
30. Suzuki S, Suzuki N, Mirtsos C, Horacek T, Lye E, Noh SK, Ho A, Bouchard D, Mak, TW and Yeh WC: Nur77 as a survival factor in tumor necrosis factor signaling. Proc Natl Acad Sci USA 100: 8276-8280, 2003.
31. Lin B, Kolluri SK, Lin F, Liu W, Han YH, Cao X, Dawson MI, Reed JC and Zhang XK: Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116: 527-540, 2004.
32. Yoo Yg, Yeo MG, Kim DK, Park H and Lee MO: Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1alpha. J Biol Chem 279: 53365-53373, 2004.
33. Ramaswamy S, Ross KN, Lander ES and Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54, 2003.
34. Ke N, Claassen G, Yu DH, Albers A, Fan W, Tan P, Grifman M, Hu X, Defife Nguy V, Meyhack B, Brachat A, Wong-Staal F and Li QX: Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res 64: 8208-8212, 2004.
35. Bandoh S, Tsukada T, Maruyama K, Ohkura N and Yamaguchi K: Differential expression of NGFI-B and RNR-1 genes in various tissues and developing brain of the rat: comparative study by quantitative reverse transcription-polymerase chain reaction. J Neuroendocrinol 9: 3-8, 1997.
36. Kakar SS, Winters SJ, Zacharias W, Miller DM and Flynn S: Identification of distinct gene expression profiles associated with treatment of LbetaT2 cells with gonadotropin-releasing hormone agonist using microarray analysis. Gene 308: 67-77, 2003.
37. Nakai A, Kartha S, Sakurai A, Toback FG and DeGroot LJ: A human early response gene homologous to murine nur77 and rat NGFI-B, and related to the nuclear receptor superfamily. Mol Endocrinol 4: 1438-1443, 1990.
38. Ryseck RP, Macdonald-Bravo H, Mattei MG, Ruppert S and Bravo R: Structure, mapping and expression of a growth factor inducible gene encoding a putative nuclear hormonal binding receptor. EMBO J 8: 3327-3335, 1989.
39. Fink G: Gonadotropin secretion and its control. In: The Physiology of Reproduction. Knobil E, Neill JD (eds). Raven, New York, pp1349-1377, 1988.
40. Kalnay A, Palyi I, Vincze B, Mihalik R, Mezo I, Pato J, Seprodi J, Lovas S and Murphy RF: Influence on antiproliferative activity of structural modification and conjugation of gonadotropin-releasing hormone (GnRH) analogues. Cell Prolif 33: 275-285, 2000.
41. Kraus S, Levy G, Hanoch T, Naor Z and Seger R: Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways. Cancer Res 64: 5736-5744, 2004.
42. Davidson L, Pawson AJ, Millar RP and Maudsley S: Cytoskeletal reorganization dependence of signaling by the gonadotropin-releasing hormone receptor. J Biol Chem 279: 1980-1993, 2004.
43. Kakar SS, Malik MT, Winters SJ and Mazhawidza W: Gonadotropin-releasing hormone receptors: structure, expression, and signaling transduction. Vitam Horm 69: 151-207, 2004.
44. Winters SJ, Ghooray D, Fuji Y, Moore JP Jr, Nevitt JR and Kakar SS: Transcriptional regulation of follistatin by GnRH in mouse gonadotroph cell lines: evidence for a role for cAMP signaling. Mol Cell Endocrinol 271: 45-54, 2007.
45. Hamid T and Kakar SS: PTTG/securin activates expression of p53 and modulates its function. Mol Cancer 8: 18, 2004.
46. De Silva S, Han S, Zhang X, Huston DP, Winoto A and Zheng B: Reduction of the incidence and severity of collagen-induced arthritis by constitutive Nur77 expression in the T cell lineage. Arthritis Rheum 52: 333-338, 2005.
47. Maxwell MA, Cleasby ME, Harding A, Stark A, Cooney GJ and Muscat GE: Nur77 regulates lipolysis in skeletal muscle cells: evidence for crosstalk between the beta-adrenergic and an orphan nuclear hormone receptor pathway. J Biol Chem 280: 12573-12584, 2005.
48. Kolluri SK, Bruey-Sedano N, Cao X, Lin B, Lin F, Han YH, Dawson MI and Zhang XK: Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol Cell Biol 23: 8651-8567, 2003.
49. Saucedo-Cardenas O and Conneely OM: Comparative distribution of NURR1 and NUR77 nuclear receptors in the mouse central nervous system. J Mol Neurosci 7: 51-63, 1996.
50. Zetterstrom RH, Solomin L, Mitsiadis T, Olson L and Perlmann T: Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1. Mol Endocrinol 10: 1656-1666, 1996.
51. Park JI, Park HJ, Choi HS, Lee K, Lee WK and Chun SY: Gonadotropin regulation of NGFI-B messenger ribonucleic acid expression during ovarian follicle development in the rat. Endocrinology 142: 3051-3059, 2001.
52. Park JI, Park HJ, Lee YI, Seo YM and Chun SY: Regulation of NGFI-B expression during the ovulatory process. Mol Cell Endocrinol 202: 25-29, 2003.
53. Honkaniemi J and Sharp FR: Prolonged expression of zinc finger immediate-early gene mRNAs and decreased protein synthesis following kainic acid induced seizures. Eur J Neurosci 11: 10-17, 1999.
54. Murphy EP and Conneely OM: Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol Endocrinol 11: 39-47, 1997.
55. Davis IJ and Lau LF: Endocrine and neurogenic regulation of the orphan nuclear receptors Nur77 and Nurr-1 in the adrenal glands. Mol Cell Biol 14: 3469-3483, 1994.
56. Bassett MH, Suzuki T, Sasano H, De Vries CJ, Jimenez PT, Carr BR and Rainey WE: The orphan nuclear receptor NGFIB regulates transcription of 3beta-hydroxysteroid dehydrogenase. Implications for the control of adrenal functional zonation. J Biol Chem 279: 37622-37630, 2004.
57. Hsu HC, Zhou T and Mountz JD: Nur77 family of nuclear hormone receptors. Curr Drug Targets Inflamm Allergy 3: 413-423, 2004.
58. Mynard V, Latchoumanin O, Guignat L, Devin-Leclerc J, Bertagna X, Barre BF, Agart J, Coqueret O and Catelli MG: Synergistic signaling by corticotropin-releasing hormone and leukemia inhibitory factor bridged by phosphorylated 3′,5′-cyclic adenosine monophosphate response element binding protein at the Nur response element (NurRE)-signal transducers and activators of transcription (STAT) element of the proopio-melanocortin promoter. Mol Endocrinol 18: 2997-3010, 2004.
59. Sadie H, Styger G and Hapgood J: Expression of the mouse gonadotropin-releasing hormone receptor gene in alpha T3-1 gonadotrope cells is stimulated by cyclic 3′,5′-adenosine monophosphate and protein kinase A, and is modulated by Steroidogenic factor-1 and Nur77. Endocrinology 144: 1958-1971, 2003.
60. Stojilkovic SS, Reinhart J and Catt KJ: Gonadotropin-releasing hormone receptors: structure and signal transduction pathways. Endocr Rev 15: 462-499, 1994.
61. Shacham S, Harris D, Ben-Shlomo H, Cohen I, Bonfil D, Przedecki F, Lewy H, Ashkenazi IE, Seger R and Naor Z: Mechanism of GnRH receptor signaling on gonadotropin release and gene expression in pituitary gonadotroph. Vitam Horm 63: 63-90, 2001.
62. Halvorson LM, Kaiser UB and Chin WW: The protein kinase C system acts through the early growth response protein 1 to increase LHbeta gene expression in synergy with steroidogenic factor-1. Mol Endocrinol 13: 106-116, 1999.
63. Pirih FQ, Nervina JM, Pham L, Aghaloo T and Tetradis S: Parathyroid hormone induces the nuclear orphan receptor NOR-1 in osteoblasts. Biochem Biophys Res Commun 306: 144-150, 2003.
64. Pichon B, Jimenez-Cervantes C, Pirson I, Maenhaut C and Christophe D: Induction of nerve growth factor-induced gene-B (NGFI-B) as an early event in the cyclic adenosine monophosphate response of dog thyrocytes in primary culture. Endocrinology 137: 4691-4698, 1996.
65. Lim RW, Zhu CY and Stringer B: Differential regulation of primary response gene expression in skeletal muscle cells through multiple signal transduction pathways. Biochim Biophys Acta 1266: 91-100, 1995.
66. Bondy GP: Phorbol ester, forskolin, and serum induction of a human colon nuclear hormone receptor gene related to the NUR 77/NGFI-B genes. Cell Growth Differ 2: 203-208, 1991.
67. Garcia I, Pipaon C, Alemany S and Perez-Castillo A: Induction of NGFI-B gene expression during T cell activation. Role of protein phosphatases. J Immunol 153: 3417-3425, 1994.
68. Rousseau G, Haddad PS, Gallo-Payet N and Bouvier M: Ca(2+)-dependent sensitization of adenylyl cyclase activity. Eur J Pharmacol 422: 53-60, 2001.
69. 2+-sensitive adenylyl cyclase in gonadotropin-releasing hormone neurons. Mol Endocrinol 15: 429-440, 2001.
70. Bourguignon JP, Gerard A, Debougnoux G, Rose J and Franchimont P: Pulsatile release of gonadotropin-releasing hormone (GnRH) from the rat hypothalamus in vitro: calcium and glucose dependency and inhibition by superactive GnRH analogs. Endocrinology 121: 993-999, 1987.
71. 2+ in the secretory and biosynthetic response of porcine gonadotropes to substance P and gonadotropin-releasing hormone. Regul Pept 116: 43-52, 2003.
72. Weck J, Fallest PC, Pitt LK and Shupnik MA: Differential gonadotropin-releasing hormone stimulation of rat luteinizing hormone subunit gene transcription by calcium influx and mitogen-activated protein kinase-signaling pathways. Mol Endocrinol 12: 451-457, 1998.
73. Vasilyev VV, Pernasetti F, Rosenberg SB, Barsoum MJ, Austin DA, Webster NJ and Mellon PL: Transcriptional activation of the ovine follicle-stimulating hormone-beta gene by gonadotropin-releasing hormone involves multiple signal transduction pathways. Endocrinology 143: 1651-1659, 2002.
74. Benard O, Naor Z and Seger R: Role of dynamin, Src, and Ras in the protein kinase C-mediated activation of ERK by gonadotropin-releasing hormone. J Biol Chem 276: 4554-4563, 2001.
75. Bonfil D, Chuderland D, Kraus S, Shahbazian D, Friedberg I, Seger R and Naor Z: Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone beta-subunit promoter. Endocrinology 145: 2228-2244, 2004.
76. Wurmbach E, Yuen T, Ebersole BJ and Sealfon SC: Gonadotropin-releasing hormone receptor-coupled gene network organization. J Biol Chem 276: 47195-47201, 2001.
77. McCann SM, Karanth S, Mastronardi CA, Dees WL, Childs G, Miller B, Sower S and Yu WH: Hypothalamic control of gonadotropin secretion. Prog Brain Res 141: 151-164, 2002.
78. Kakar SS, Musgrove LC, Devor DC, Sellers JC and Neill JD: Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res Commun 189: 289-295, 1992.
79. Whitelaw PF, Eidne KA, Sellar R, Smyth CD and Hillier SG: Gonadotropin-releasing hormone receptor messenger ribonucleic acid expression in rat ovary. Endocrinology 136: 172-179, 1995.
80. Latouche J, Crumeyrolle-Arias M, Jordan D, Kopp N, Augendre-Ferrante B, Cedard L and Haour F: GnRH receptors in human granulosa cells: anatomical localization and characterization by autoradiographic study. Endocrinology 125: 1739-1741, 1989.
81. Peng C, Fan NC, Ligier M, Vaananen J and Leung PC: Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology 135: 1740-1746, 1994.
82. Minaretzis D, Jakubowski M, Mortola JF and Pavlou SN: Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells. J Clin Endocrinol Metab 80: 430-434, 1995.
83. Limonta P, Moretti RM, Marelli MM and Motta M: The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Front Neuroendocrinol 24: 279-295, 2003.
84. Kang SK, Choi KC, Yang HS and Leung PC: Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer. Endocr Relat Cancer 10: 169-177, 2003.
85. Moretti RM, Monagnani Marelli M, van Groeninghen JC, Motta M and Limonta P: Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression. Endocr Relat Cancer 10: 161-167, 2003.
86. Irmer G, Burger C, Ortmann O, Schulz KD and Emons G: Expression of luteinizing hormone releasing hormone and its mRNA in human endometrial cancer cell lines. J Clin Endocrinol Metab 79: 916-919, 1994.
87. Kakar SS and Jennes L: Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues. Cancer Lett 98: 57-62, 1995.
88. Schally AV, Comaru-Schally AM, Nagy A, Kovacs M, Szepeshazi K, Plonowski A, Varga JL and Halmos G: Hypothalamic hormones and cancer. Front Neuroendocrinol 22: 248-291, 2001.
89. Szepeshazi K, Schally AV and Halmos G: LH-RH receptors in human colorectal cancers: unexpected molecular targets for experimental therapy. Int J Oncol 30: 1485-1492, 2007.
90. Gaiser T, Ruschoff J, Schally AV, Keller G and Engel JB: Receptor for luteinizing hormone releasing hormone expressed on melanoma, renal cell carcinoma and non Hodgkin lymphoma can be used for targeted chemotherapy with cytotoxic luteinizing hormone analogues. Verh dtsch Ges Pathol 90: 186-192, 2006.
91. Wang Y, Matsuo H, Kurachi O and Maruo T: Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells. Eur J Endocrinol 146: 447-456, 2002.
92. Grundker C and Emons G: Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer. Reprod Biol Endocrinol 1: 65, 2003.
93. Chen CL, Cheung LW, Lau MT, Choi JH, Auersperg N, Wang HS, Wong AS and Leung PC: Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion. Endocrine 31: 311-320, 2007.
94. Montagnani Marelli M, Moretti RM, Mai S, Procacci P and Limonta P: Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-1. Int J Oncol 30: 261-271, 2007.